跳至主要内容
临床试验/NCT06011408
NCT06011408Unknown不适用

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

iRxReminder4 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年5月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
4
主要终点
AIMS Score

研究概览

简要总结

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

详细描述

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia. Participants will all be taking an antipsychotic medication and half will have a diagnosis of Tardive Dyskinesia and half will not. Participant responses to interview questions and elements of the Abnormal Involuntary Movement Scale will be collected on video. The videos will be rated by trained observers. Machine learning methods will be used to develop an algorithm to detect abnormal movements in individuals with a known Tardive Dyskinesia diagnosis. The trained rater results will be compared to the algorithm to determine the accuracy of the algorithm.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For the non-TD group:
  • Prescribed and taking an antipsychotic medication for 90-days or longer.
  • Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
  • Signed an informed consent.
  • Speaks English fluently.

排除标准

  • Suffered a moderate or severe head injury in the last year;
  • History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
  • Severe visual impairment that is cannot be corrected by glasses or contacts.

研究组 & 干预措施

Taking antipsychotic medication with Tardive Dyskinesia

Other

干预措施: TDtect (Other)

Taking antipsychotic medication without Tardive Dyskinesia

Other

干预措施: TDtect (Other)

结局指标

主要结局

AIMS Score

时间窗: Baseline

Abnormal Involuntary Scale Score

次要结局

未报告次要终点

研究者

发起方
iRxReminder
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验